DEWPOINT Trademark

Trademark Overview


On Wednesday, February 15, 2023, a trademark application was filed for DEWPOINT with the United States Patent and Trademark Office. The USPTO has given the DEWPOINT trademark a serial number of 97796171. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 4, 2024. This trademark is owned by Dewpoint Therapeutics, Inc.. The DEWPOINT trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations and therapeutic agents for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, women's health in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases and wound healing; reagents for medical use; Reagents for clinical use in the nature of clinical medical use

Reagents for research use; Reagents for research purposes of drug discovery and development; Reagents for clinical use in the nature of diagnostic reagents for clinical and medical laboratory use
dewpoint

General Information


Serial Number97796171
Word MarkDEWPOINT
Filing DateWednesday, February 15, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations and therapeutic agents for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, women's health in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases and wound healing; reagents for medical use; Reagents for clinical use in the nature of clinical medical use
Pseudo MarkDEW POINT
Goods and ServicesReagents for research use; Reagents for research purposes of drug discovery and development; Reagents for clinical use in the nature of diagnostic reagents for clinical and medical laboratory use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, March 6, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDewpoint Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Party NameDewpoint Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Tuesday, November 14, 2023ASSIGNED TO EXAMINER
Monday, November 27, 2023NON-FINAL ACTION WRITTEN
Monday, November 27, 2023NON-FINAL ACTION E-MAILED
Monday, November 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2024PUBLISHED FOR OPPOSITION
Saturday, February 18, 2023NEW APPLICATION ENTERED
Monday, March 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT